187 related articles for article (PubMed ID: 11646190)
21. Panel advises F.D.A. to allow abortion pill.
Kolata G
N Y Times Web; 1996 Jul; ():1, 7. PubMed ID: 11647507
[No Abstract] [Full Text] [Related]
22. Mandating research with children.
Baylis F
IRB; 1999; 21(1):10-1. PubMed ID: 11657966
[No Abstract] [Full Text] [Related]
23. AIDS study casts doubt on value of hastened drug approval in U.S.
Altman LK
N Y Times Web; 1993 Apr; ():C3. PubMed ID: 11646977
[No Abstract] [Full Text] [Related]
24. AIDS and drug pricing: in search of a policy.
Salbu SR
Wash Univ Law Q; 1993; 71(3):691-734. PubMed ID: 11652750
[No Abstract] [Full Text] [Related]
25. Women and HIV/AIDS research: the barriers to equity.
Levine C
IRB; 1991; 13(1-2):18-22. PubMed ID: 11659324
[No Abstract] [Full Text] [Related]
26. F.D.A. will require companies to test drugs on children.
Pear R
N Y Times Web; 1998 Nov; ():A1, A10. PubMed ID: 11647619
[No Abstract] [Full Text] [Related]
27. F.D.A. approves home AIDS test: marketing is to begin in June.
Leary WE
N Y Times Web; 1996 May; ():A15. PubMed ID: 11647120
[No Abstract] [Full Text] [Related]
28. F.D.A. investigated the unauthorized Arizona implant last week: learning to live with the artificial heart.
Altman LK
N Y Times Web; 1985 Mar; ():E7. PubMed ID: 11646456
[No Abstract] [Full Text] [Related]
29. Plans for mail-in kit for testing for AIDS drawing criticism.
Miller LB
N Y Times Web; 1987 Aug; ():A1, A24. PubMed ID: 11646588
[No Abstract] [Full Text] [Related]
30. Informed consent: the FDA's perspective.
Bagley G
Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141
[No Abstract] [Full Text] [Related]
31. Rules to protect drug-test participants via follow-up exams are slated by FDA.
Spivak J
Wall St J (East Ed); 1976 Mar; ():5. PubMed ID: 11649042
[No Abstract] [Full Text] [Related]
32. Military medical research: 2. Proving the safety and effectiveness of a nerve gas antidote -- a legal view.
Cooper RM
IRB; 1989; 11(4):7-9. PubMed ID: 11650245
[No Abstract] [Full Text] [Related]
33. The Food and Drug Administration's role in the protection of human subjects.
Nightingale SL
IRB; 1983; 5(1):6-9. PubMed ID: 11649511
[No Abstract] [Full Text] [Related]
34. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures.
Dunbar MM
Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380
[No Abstract] [Full Text] [Related]
35. F.D.A. sets rules on artificial heart implants.
Boffey PM
N Y Times Web; 1986 Jan; ():A15. PubMed ID: 11646521
[No Abstract] [Full Text] [Related]
36. High cost of high-tech drugs is protested.
Pollack A
N Y Times Web; 1988 Feb; ():A1, D23. PubMed ID: 11646656
[No Abstract] [Full Text] [Related]
37. Proposal to test drugs in children meets resistance.
Pear R
N Y Times Web; 1997 Nov; ():1, 28. PubMed ID: 11647286
[No Abstract] [Full Text] [Related]
38. AIDS in the workplace: the Administration's impeccable logic.
Fein B
N Y Times Web; 1986 Jul; ():Sect. 3, p. 2. PubMed ID: 11646166
[No Abstract] [Full Text] [Related]
39. The right of privacy in choosing medical treatment: should terminally ill persons have access to drugs not yet approved by the Food and Drug Administration?
Power SH
John Marshall Law Rev; 1987; 20(4):693-714. PubMed ID: 11650094
[No Abstract] [Full Text] [Related]
40. Protecting human research subjects and the public: the role of FDA disqualification of clinical investigators.
Nightingale SL
Food Drug Cosmet Law J; 1980 Sep; 35(9):484-92. PubMed ID: 11661914
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
